P3: Pacemaker Patient Profiling Study

Stopped early

Conditions studied: Bradycardia

In brief

The P3 Study is a United States post market study to gather data on clinical status, primary indications, device therapy choices, clinical management and outcomes for patients with implantable pacemakers.

Key facts

Study ID

NCT00294060

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

2013

Starts

2004-03-01

Expected to finish

2007-11-01

Last updated by the study team

2011-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient meets Class I / Class II indications for pacing
• Patient implanted with one of the following market-approved single or dual chamber Medtronic devices: EnRhythm™, EnPulse®, Kappa® 700, Kappa® 900, Vitatron Clarity™, Vitatron Selection® AFm, Vitatron C-Series, Vitatron T-Series, or the AT500™ DDDR Pacing System

You may not qualify if…

• Patient is enrolled in a device or cardiovascular drug study that affects treatment and/or study device programming
• Patient whose life expectancy is less than two years

Where it is running

• Study site — Prescott, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Aliso Viejo, California, United States
• Study site — Anaheim, California, United States
• Study site — Arcadia, California, United States
• Study site — Escondido, California, United States
• Study site — Fountain Valley, California, United States
• Study site — La Mesa, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Mission Viejo, California, United States
• Study site — Orange, California, United States
• Study site — Riverside, California, United States
• Study site — Tarzana, California, United States
• Study site — Whittier, California, United States
• Study site — Wildomar, California, United States
• Study site — Denver, Colorado, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Lauderdale Lakes, Florida, United States
• Study site — Melbourne, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Sarasota, Florida, United States
• Study site — Vero Beach, Florida, United States
• Study site — Lawrenceville, Georgia, United States
• Study site — Idaho Falls, Idaho, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.